Aristotle Capital Boston »

Supernus Pharmaceuticals shares owned by Aristotle Capital Boston

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Aristotle Capital Boston from 13F filings

Historical chart of Aristotle Capital Boston investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Aristotle Capital Boston consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Aristotle Capital Boston

Quarter filed Position value Share count Share price at filing
2023-09-30 $33M 1.2M 27.57
2023-06-30 $35M 1.2M 30.06
2023-03-31 $42M 1.2M 36.23
2022-12-31 $40M 1.1M 35.67
2022-09-30 $39M 1.2M 33.85
2022-06-30 $37M 1.3M 28.92
2022-03-31 $41M 1.3M 32.32
2021-12-31 $38M 1.3M 29.16
2021-09-30 $35M 1.3M 26.67
2021-06-30 $33M 1.1M 30.79
2021-03-31 $26M 973k 26.18
2020-12-31 $26M 1.0M 25.16
2020-09-30 $22M 1.1M 20.84
2020-06-30 $24M 1.0M 23.75
2020-03-31 $13M 741k 17.99
2019-12-31 $18M 758k 23.72
2019-09-30 $20M 744k 27.48
2019-06-30 $3.4M 104k 33.09